NASDAQ : OABI
OmniAb, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 5.11 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 742.94M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
OmniAb, Inc. (OABI) reported revenue of 40.21M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 38.26M | 17.91M | 26.39M | 34.16M | 59.08M | 34.75M |
| Other Revenue | 1.95M | 754.00K | ||||
| Revenue | 40.21M | 18.67M | 26.39M | 34.16M | 59.08M | 34.75M |
| Cost of Revenue | 943.00K | 303.00K | ||||
| Gross Profit | 39.27M | 18.36M | 26.39M | 34.16M | 59.08M | 34.75M |
| Selling, General & Admin | 32.09M | 33.95M | 35.73M | 38.01M | 29.23M | 19.17M |
| Research & Development | 34.66M | 39.72M | 50.12M | 51.83M | 44.04M | 37.01M |
| Amortization of Goodwill & Intangibles | 12.46M | 12.91M | 13.51M | 13.55M | 13.05M | 12.97M |
| Other Operating Expenses | -2.58M | -2.87M | 182.00K | -150.00K | ||
| Operating Expenses | 76.63M | 83.71M | 99.54M | 103.24M | 86.32M | 69.15M |
| Operating Income | -37.36M | -65.34M | -73.15M | -69.08M | -27.24M | -34.40M |
| Interest Expense | -7.00K | |||||
| Interest & Investment Income | 2.67M | 2.66M | 3.11M | 5.05M | 587.00K | |
| Other Non Operating Income (Expenses) | 52.00K | 15.00K | -15.00K | 1.00K | 1.00K | |
| EBT Excluding Unusual Items | -34.64M | -62.67M | -70.06M | -64.02M | -26.65M | -34.41M |
| Gain (Loss) on Sale of Investments | 1.26M | |||||
| Gain (Loss) on Sale of Assets | -3.00M | |||||
| Asset Writedown | -6.20M | -3.30M | -3.90M | |||
| Other Unusual Items | -40.00K | -325.00K | 2.55M | -341.00K | 592.00K | -1.21M |
| Pretax Income | -43.88M | -66.29M | -71.41M | -64.36M | -26.06M | -34.35M |
| Income Tax Expense | -405.00K | -1.51M | -9.38M | -13.74M | -3.73M | -7.31M |
| Net Income | -43.47M | -64.78M | -62.03M | -50.62M | -22.33M | -27.04M |
| Net Income to Common | -43.47M | -64.78M | -62.03M | -50.62M | -22.33M | -27.04M |
| Shares Outstanding (Basic) | 128.57M | 113.64M | 102.36M | 99.68M | 85.32M | 82.61M |
| Shares Outstanding (Diluted) | 128.57M | 113.64M | 102.36M | 99.68M | 85.32M | 82.61M |
| EPS (Basic) | -0.34 | -0.57 | -0.61 | -0.51 | -0.26 | -0.33 |
| EPS (Diluted) | -0.34 | -0.57 | -0.61 | -0.51 | -0.26 | -0.33 |
| Free Cash Flow | 2.38M | -37.02M | -41.54M | 703.00K | -20.75M | -9.74M |
| Free Cash Flow Per Share | 0.02 | -0.33 | -0.41 | 0.01 | -0.24 | -0.12 |
| Gross Margin | 97.66% | 98.38% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -92.91% | -350.07% | -277.17% | -202.19% | -46.11% | -99.00% |
| Profit Margin | -108.11% | -347.04% | -235.05% | -148.16% | -37.80% | -77.82% |
| Free Cash Flow Margin | 5.92% | -198.33% | -157.40% | 2.06% | -35.13% | -28.04% |
| EBITDA | -20.31M | -46.89M | -53.47M | -49.58M | -8.99M | -18.15M |
| EBITDA Margin | -50.50% | -251.20% | -202.59% | -145.13% | -15.22% | -52.22% |
| D&A For EBITDA | 17.05M | 18.45M | 19.68M | 19.50M | 18.25M | 16.25M |
| EBIT | -37.36M | -65.34M | -73.15M | -69.08M | -27.24M | -34.40M |
| EBIT Margin | -92.91% | -277.17% | -202.19% | -46.11% | -99.00% | |
| Revenue as Reported | 40.21M | 18.67M | 26.39M | 34.16M | 59.08M | 34.75M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 22.88M | 25.52M | 27.60M | 16.36M | 33.39M | |
| Short-Term Investments | 41.33M | 28.50M | 31.84M | 70.62M | 54.88M | |
| Cash & Short-Term Investments | 64.21M | 54.02M | 59.43M | 86.98M | 88.27M | |
| Receivables | 2.57M | 7.39M | 5.27M | 3.84M | 30.29M | 21.14M |
| Prepaid Expenses | 2.79M | 3.93M | 3.43M | 4.07M | 6.39M | 1.41M |
| Other Current Assets | 333.00K | |||||
| Total Current Assets | 70.98M | 65.34M | 68.14M | 94.90M | 124.95M | 22.54M |
| Property, Plant & Equipment | 21.80M | 24.97M | 33.28M | 38.13M | 41.46M | 20.13M |
| Goodwill | 83.98M | 83.98M | 83.98M | 83.98M | 83.98M | 83.98M |
| Other Intangible Assets | 113.02M | 125.15M | 138.06M | 155.47M | 167.24M | 176.32M |
| Other Long-Term Assets | 1.14M | 1.47M | 2.10M | 2.75M | 3.58M | 1.50M |
| Total Assets | 290.92M | 300.91M | 325.56M | 375.23M | 421.21M | 304.46M |
| Accounts Payable | 1.41M | 1.88M | 2.30M | 4.41M | 2.97M | 2.92M |
| Accrued Expenses | 5.13M | 6.12M | 5.93M | 5.82M | 5.50M | 2.68M |
| Current Portion of Leases | 4.00M | 3.88M | 3.78M | 3.49M | 1.78M | 578.00K |
| Current Income Taxes Payable | 3.48M | |||||
| Current Unearned Revenue | 5.24M | 3.16M | 2.34M | 6.85M | 8.21M | 10.79M |
| Other Current Liabilities | 1.07M | 1.22M | 737.00K | 2.55M | 4.08M | 3.60M |
| Total Current Liabilities | 16.85M | 16.25M | 15.09M | 23.12M | 26.02M | 20.58M |
| Long-Term Leases | 14.13M | 16.45M | 19.38M | 22.07M | 24.02M | 13.27M |
| Long-Term Unearned Revenue | 9.73M | 117.00K | 862.00K | 4.33M | 9.23M | |
| Long-Term Deferred Tax Liabilities | 756.00K | 785.00K | 2.31M | 11.35M | 21.34M | 21.96M |
| Other Long-Term Liabilities | 283.00K | 393.00K | 1.04M | 3.23M | 4.13M | 5.12M |
| Total Liabilities | 41.76M | 33.89M | 37.94M | 60.64M | 79.84M | 70.16M |
| Common Stock | 15.00K | 14.00K | 12.00K | 12.00K | 12.00K | 234.31M |
| Additional Paid-In Capital | 444.69M | 433.18M | 388.98M | 353.89M | 330.10M | |
| Retained Earnings | -195.47M | -166.18M | -101.40M | -39.37M | 11.25M | |
| Comprehensive Income & Other | -72.00K | 12.00K | 27.00K | 50.00K | 9.00K | |
| Shareholders' Equity | 249.16M | 267.03M | 287.62M | 314.58M | 341.37M | 234.31M |
| Total Liabilities & Equity | 290.92M | 300.91M | 325.56M | 375.23M | 421.21M | 304.46M |
| Total Debt | 18.14M | 20.33M | 23.16M | 25.56M | 25.80M | 13.85M |
| Net Cash (Debt) | 46.07M | 33.69M | 36.27M | 61.42M | 62.47M | -13.85M |
| Net Cash Per Share | 0.36 | 0.30 | 0.35 | 0.62 | 0.73 | -0.17 |
| Filing Date Shares Outstanding | 145.86M | 144.78M | 122.13M | 117.13M | 115.58M | 82.61M |
| Total Common Shares Outstanding | 145.86M | 144.31M | 121.60M | 116.86M | 115.22M | 82.61M |
| Working Capital | 54.12M | 49.09M | 53.05M | 71.78M | 98.93M | 1.97M |
| Book Value Per Share | 1.71 | 1.85 | 2.37 | 2.69 | 2.96 | 2.84 |
| Tangible Book Value | 52.17M | 57.90M | 65.58M | 75.14M | 90.15M | -25.99M |
| Tangible Book Value Per Share | 0.36 | 0.40 | 0.54 | 0.64 | 0.78 | -0.31 |
| Machinery | 11.08M | 10.97M | 10.54M | 10.21M | 8.77M | 5.78M |
| Construction In Progress | 22.00K | 46.00K | 103.00K | 842.00K | 315.00K | 2.99M |
| Leasehold Improvements | 17.75M | 17.75M | 17.75M | 16.08M | 16.09M | 1.32M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -43.47M | -64.78M | -62.03M | -50.62M | -22.33M | -27.04M |
| Depreciation & Amortization | 17.15M | 18.45M | 19.68M | 19.50M | 18.25M | 16.25M |
| Loss (Gain) From Sale of Assets | -3.00M | |||||
| Asset Writedown & Restructuring Costs | 6.20M | 3.30M | 3.90M | |||
| Loss (Gain) From Sale of Investments | -784.00K | -858.00K | -1.50M | -3.44M | -170.00K | -1.26M |
| Stock-Based Compensation | 13.16M | 15.82M | 21.50M | 24.82M | 18.32M | 15.06M |
| Other Operating Activities | 255.00K | -443.00K | -11.04M | -12.78M | -6.82M | -6.05M |
| Change in Accounts Receivable | 2.71M | 189.00K | -625.00K | 26.90M | -12.74M | 6.02M |
| Change in Accounts Payable | -82.00K | -231.00K | -2.41M | 920.00K | 15.07M | 1.51M |
| Change in Unearned Revenue | 11.15M | -1.60M | -5.99M | -5.35M | -9.49M | -6.72M |
| Change in Other Net Operating Assets | -3.62M | -3.31M | -1.15M | 2.40M | -3.67M | -3.45M |
| Operating Cash Flow | 2.67M | -36.45M | -39.66M | 2.35M | -3.59M | -5.67M |
| Capital Expenditures | -286.00K | -565.00K | -1.88M | -1.64M | -17.17M | -4.07M |
| Sale of Property, Plant & Equipment | 3.00M | |||||
| Investment in Securities | -9.68M | 4.03M | 40.16M | -12.29M | -54.70M | 1.26M |
| Other Investing Activities | -400.00K | -4.44M | -1.44M | -1.22M | ||
| Investing Cash Flow | -9.96M | 6.47M | 37.88M | -18.38M | -73.31M | -4.03M |
| Issuance of Common Stock | 2.10M | 28.69M | 14.63M | 1.21M | 96.87M | |
| Repurchase of Common Stock | -960.00K | -1.32M | -189.00K | |||
| Other Financing Activities | -461.00K | -774.00K | -646.00K | -773.00K | 14.06M | 9.70M |
| Financing Cash Flow | 1.64M | 27.91M | 13.02M | -892.00K | 110.74M | 9.70M |
| Net Cash Flow | -5.65M | -2.07M | 11.24M | -16.92M | 33.84M | |
| Free Cash Flow | 2.38M | -37.02M | -41.54M | 703.00K | -20.75M | -9.74M |
| Free Cash Flow Margin | 5.92% | -198.33% | -157.40% | 2.06% | -35.13% | -28.04% |
| Free Cash Flow Per Share | 0.02 | -0.33 | -0.41 | 0.01 | -0.24 | -0.12 |
| Levered Free Cash Flow | 10.19M | -8.67M | -15.52M | 23.65M | -7.52M | 6.15M |
| Unlevered Free Cash Flow | 10.19M | -8.67M | -15.52M | 23.65M | -7.52M | 6.16M |
| Cash Income Tax Paid | 2.61M | |||||
| Change in Working Capital | 10.16M | -4.95M | -10.17M | 24.87M | -10.83M | -2.63M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 745.35M | 266.32M | 428.38M | 717.57M | 413.36M | |
| Enterprise Value | 699.27M | 227.89M | 392.84M | 647.12M | 439.90M | |
| Last Close Price | 5.11 | 1.85 | 3.54 | 6.17 | 3.60 | |
| PS Ratio | 18.54 | 14.27 | 16.23 | 21.00 | 7.00 | |
| PB Ratio | 2.99 | 1.00 | 1.49 | 2.28 | 1.21 | |
| P/TBV Ratio | 14.29 | 4.60 | 6.53 | 9.55 | 4.58 | |
| P/FCF Ratio | 313.17 | 1,020.73 | ||||
| P/OCF Ratio | 279.57 | 305.74 | ||||
| EV/Sales Ratio | 17.39 | 12.21 | 14.88 | 18.94 | 7.45 | |
| EV/FCF Ratio | 293.81 | 920.51 | ||||
| Debt / Equity Ratio | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 |
| Debt / FCF Ratio | 7.62 | 36.36 | ||||
| Net Debt / Equity Ratio | -0.18 | -0.13 | -0.13 | -0.20 | -0.18 | 0.06 |
| Net Debt / EBITDA Ratio | 2.27 | 0.72 | 0.68 | 1.24 | 6.95 | -0.76 |
| Net Debt / FCF Ratio | -19.36 | 0.91 | 0.87 | -87.37 | 3.01 | -1.42 |
| Asset Turnover | 0.13 | 0.06 | 0.07 | 0.09 | 0.16 | 0.12 |
| Quick Ratio | 3.96 | 3.78 | 4.29 | 3.93 | 4.56 | 1.03 |
| Current Ratio | 4.21 | 4.02 | 4.52 | 4.11 | 4.80 | 1.09 |
| Return on Equity (ROE) | -16.51% | -23.36% | -20.60% | -15.43% | -7.76% | -11.51% |
| Return on Assets (ROA) | -7.78% | -13.04% | -13.05% | -10.84% | -4.69% | -7.17% |
| Return on Capital Employed (ROCE) | -13.60% | -23.00% | -23.60% | -19.60% | -6.90% | -12.10% |
| Earnings Yield | -6.62% | -24.32% | -14.48% | -7.05% | -5.40% | |
| FCF Yield | 0.32% | -13.90% | -9.70% | 0.10% | -5.02% | |
| Buyback Yield / Dilution | -19.20% | -11.01% | -2.69% | -16.84% | -3.28% |